2552 — Hua Medicine Share News
0.000.00%
Last trade - 00:00- HK$2.25bn
- HK$1.40bn
- CNY492.93m
Brief: Hua Medicine Posts H1 Adjusted Loss Of About RMB193.5 Mln
Brief: Hua Medicine Initiates First Combination Study Of Dorzagliatin With A Dpp-4 Inhibitor In United States
China biotech Junshi Biosciences seeks up to $414mln in Hong Kong IPO
China's Innovent Biologics looks to raise up to $422 mln in HK IPO - sources
HK-listed Hua Medicine falls below IPO price on trading debut